“I buy on the assumption that they could close the market the next day and not reopen it for five years.”
— Warren Buffett
The Warren Buffett investment philosophy calls for a long-term investment horizon, where a five year holding period, or even longer, would fit right into the strategy. How would such a strategy have worked out for an investment into Regeneron Pharmaceuticals, Inc. (NASD: REGN)? Today, we examine the outcome of a five year investment into the stock back in 2015.
| Start date: | 04/29/2015 |
|
|||
| End date: | 04/28/2020 | ||||
| Start price/share: | $469.70 | ||||
| End price/share: | $528.61 | ||||
| Starting shares: | 21.29 | ||||
| Ending shares: | 21.29 | ||||
| Dividends reinvested/share: | $0.00 | ||||
| Total return: | 12.54% | ||||
| Average annual return: | 2.39% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $11,254.23 | ||||
As shown above, the five year investment result worked out as follows, with an annualized rate of return of 2.39%. This would have turned a $10K investment made 5 years ago into $11,254.23 today (as of 04/28/2020). On a total return basis, that’s a result of 12.54% (something to think about: how might REGN shares perform over the next 5 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
More investment wisdom to ponder:
“In the long run, we are all dead.” — John Maynard Keynes
